Greenwich LifeSciences, Inc.
GLSINASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $224.00M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $7.78$34.10
- Volume (live)
- -
- Avg. volume (3M)
- 127.46K
Greenwich LifeSciences (GLSI) Stock Price & Financial Analysis
Greenwich LifeSciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $14.41 - $15.53 |
|---|---|
| 52-Week High | $34.10 |
| 52-Week Low | $7.78 |
| Open | $15.30 |
| Volume (last close) | 107.67K |
| Average Volume (3M) | 127.46K |
| 50-Day MA | $16.61 |
|---|---|
| 200-Day MA | $21.98 |
| 1-Year Change | +61.43% |
| Market Cap | 224.00M |
|---|---|
| Shares Outstanding | 14.62M |
| Price to Book (P/B) | 71.86 |
| EV/EBITDA | -9.86 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Greenwich LifeSciences at a Glance
As of the Oct 16, 2026 close, Greenwich LifeSciences (GLSI) has a market capitalization of $224.00M.
As of its latest reported balance sheet, it holds $8.88M in cash and securities against $0.00 of debt, a net cash position of $8.88M.
Greenwich LifeSciences does not currently pay a dividend.
The share price is up 61.4% over the past year. At $14.55 (the Oct 16, 2026 close) it sits within its 52-week range of $7.78 to $34.10, below its 200-day moving average of $21.98.
Frequently Asked Questions About Greenwich LifeSciences
What is the current stock price for GLSI?
As of the Oct 16, 2026 close, GLSI stock trades at $14.55. The 52-week range is $7.78–$34.10, with a day range of $14.41–$15.53.
What is the P/E ratio for GLSI?
The P/E ratio (Price-to-Earnings) for GLSI is shown in the Key Statistics section. This valuation metric helps compare Greenwich LifeSciences, Inc. to industry peers.
Does GLSI pay dividends?
Greenwich LifeSciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for GLSI?
Analyst ratings and recommendations for GLSI are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of GLSI?
As of the Oct 16, 2026 close, Greenwich LifeSciences's market capitalization is $212.7M, classifying it as a micro-cap company. Greenwich LifeSciences operates in the Healthcare sector within the Biotechnology industry.